Gilead partners with Tubulis to develop solid tumour ADC
The German drugmaker will receive an upfront payment of $20m, a separate option exercise fee of $30m, and is eligible to receive up to $415m in milestone payments, in addition...
A leading resource for the Pharmaceutical industry since 2002
The German drugmaker will receive an upfront payment of $20m, a separate option exercise fee of $30m, and is eligible to receive up to $415m in milestone payments, in addition...
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry